BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.56 Cr | ₹2.18 Cr | ₹1.83 Cr | ₹1.48 Cr | ₹1.14 Cr |
What is the latest Long Term Provisions ratio of BETA DRUGS ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹2.56 Cr |
| Mar2024 | ₹2.18 Cr |
| Mar2023 | ₹1.83 Cr |
| Mar2022 | ₹1.48 Cr |
| Mar2021 | ₹1.14 Cr |
How is Long Term Provisions of BETA DRUGS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.56 Cr | 17.35 | |
| Mar2024 | ₹2.18 Cr | 19.14 | |
| Mar2023 | ₹1.83 Cr | 24.00 | |
| Mar2022 | ₹1.48 Cr | 29.84 | |
| Mar2021 | ₹1.14 Cr | - | |
Compare Long Term Provisions of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,431.2 Cr | -7.3% | 39.7% | 19.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -7.3% |
39.7% |
19.3% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses